Cargando…

A survey of risk tolerance to multiple sclerosis therapies

OBJECTIVE: To determine tolerance to various risk scenarios associated with current multiple sclerosis (MS) therapies. METHODS: People with MS from the North American Research Committee on Multiple Sclerosis Registry's online cohort and the National Multiple Sclerosis Society were invited to co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Robert J., Cosenza, Carol, Cripps, Lauren, Ford, Paul, Mercer, MaryBeth, Natarajan, Sneha, Salter, Amber, Tyry, Tuula, Cofield, Stacey S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448448/ https://www.ncbi.nlm.nih.gov/pubmed/30867272 http://dx.doi.org/10.1212/WNL.0000000000007245

Ejemplares similares

Health Literacy Association With Health Behaviors and Health Care Utilization in Multiple Sclerosis: A Cross-Sectional Study
por: Marrie, Ruth Ann, et al.
Publicado: (2014)

Preferred Sources of Health Information in Persons With Multiple Sclerosis: Degree of Trust and Information Sought
por: Marrie, Ruth Ann, et al.
Publicado: (2013)

Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Patient perspectives on switching disease-modifying therapies in the NARCOMS registry
por: Salter, Amber R, et al.
Publicado: (2014)

National estimates of self-reported sitting time in adults with multiple sclerosis
por: Sasaki, JE, et al.
Publicado: (2018)

Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice
por: Longbrake, Erin E, et al.
Publicado: (2016)

Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple Sclerosis
por: Salter, Amber, et al.
Publicado: (2022)

Attitudes of people with multiple sclerosis toward brain donation
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Clinical trials in multiple sclerosis: milestones
por: Zhang, Yinan, et al.
Publicado: (2018)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey
por: Rinker, John R, et al.
Publicado: (2015)

Era of COVID-19 in Multiple Sclerosis Care
por: Krett, Jonathan D., et al.
Publicado: (2023)

Evolution of clinical trials in multiple sclerosis
por: Zhang, Yinan, et al.
Publicado: (2019)

Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis
por: O'Mahony, Julia, et al.
Publicado: (2022)

Severity and worsening of fatigue among individuals with multiple sclerosis
por: Salter, Amber, et al.
Publicado: (2023)

A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis
por: Tardo, Lauren, et al.
Publicado: (2023)

Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
por: Porwal, Mokshal H., et al.
Publicado: (2022)

GRANDPARENTS CARING FOR GRANDCHILDREN: HOW AGE AND AGING IMPACT PROVISION OF CHILDCARE
por: Apriceno, MaryBeth A, et al.
Publicado: (2019)

Online direct-to-consumer messages about non-invasive prenatal genetic testing
por: Farrell, Ruth M., et al.
Publicado: (2016)

A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod
por: Salter, Amber, et al.
Publicado: (2021)

Self-tolerance in multiple sclerosis
por: Gonsette, R. E.
Publicado: (2012)

Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
por: Zhang, Yinan, et al.
Publicado: (2021)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI
por: Levasseur, Victoria A., et al.
Publicado: (2022)

Regional Gray Matter Atrophy in Relapsing Remitting Multiple Sclerosis: Baseline Analysis of Multi-Center Data
por: Datta, Sushmita, et al.
Publicado: (2015)

Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)

Actividades acuáticas : ejercicios de tonificación, cardiovasculares y de rehabilitación/
por: Gaines, MaryBeth Pappas, 1957-
Publicado: (1998)

Clinical trials in multiple sclerosis: potential future trial designs
por: Manouchehri, Navid, et al.
Publicado: (2019)

“Salt in the Wound”: Safety Net Clinician Perspectives on Performance Feedback Derived From EHR Data
por: Bunce, Arwen E., et al.
Publicado: (2017)

Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study()
por: Narayana, Ponnada A., et al.
Publicado: (2012)

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
por: Salter, Amber, et al.
Publicado: (2021)

Ethnographic process evaluation in primary care: explaining the complexity of implementation
por: Bunce, Arwen E, et al.
Publicado: (2014)

Body Mass Index Is Associated With Mucosal Disease in Crohn’s: Results of a Case-Control Study
por: Malik, Talha A., et al.
Publicado: (2014)

An integrative review of social and occupational factors influencing health and wellbeing
por: Gallagher, MaryBeth, et al.
Publicado: (2015)

Melanoma Among Non-Hispanic Black Americans
por: Culp, MaryBeth B., et al.
Publicado: (2019)

Dendritic Cells and Multiple Sclerosis: Disease, Tolerance and Therapy
por: Mohammad, Mohammad G., et al.
Publicado: (2012)

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
por: Zhang, Yinan, et al.
Publicado: (2020)

Improving the efficiency of clinical trials in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v53qse1tvb7ru47d1s739n8j7g